Alpha Tau Medical LTD.: Skin Neoplasms trials
The registry lists 10 Skin Neoplasms studies with Alpha Tau Medical LTD. as lead sponsor. 5 are open to participants now and 0 have results posted.
No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised PatientsRecruitingNCT06615635Not applicable
- Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCCRecruitingNCT05047094Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue NeoplasiaRecruitingNCT04534127Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous TumorsRecruitingNCT04068155Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.RecruitingNCT03889899Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell CarcinomaActive, not recruitingNCT05323253Not applicable
- Retreatment With Intratumoral Diffusing Alpha Radiation EmittersCompletedNCT04540588Not applicable
- Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue TumorsCompletedNCT04377360Not applicable
- Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)TerminatedNCT03886181Not applicable
- Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)Active, not recruitingNCT03737734Not applicable